共 257 条
[1]
Sjöström L(2004)Lifestyle, diabetes and cardiovascular risk factor ten years after bariatric surgery N Engl J Med 351 2683-2693
[2]
Lindroos AK(2007)Long-term mortality after gastric bypass surgery N Engl J Med 357 753-761
[3]
Peltonen M(2013)Metabolic effects of bariatric surgery in patients with moderate obesity and type 2 diabetes: analysis of a randomized control trial comparing surgery with intensive medical treatment Diabetes Care 36 2175-2182
[4]
Torgerson J(2016)Mechanisms of surgical control of type 2 diabetes: GLP-1 is key factor Surg Obes Relat Dis 12 1236-1242
[5]
Bouchard C(2004)Bariatric surgery: a systematic review and meta-analysis JAMA 292 1724-1737
[6]
Carlsson B(2007)Incretin levels and effect are markedly enhanced 1 month after Roux-en-Y gastric bypass surgery in obese patients with type 2 diabetes Diabetes Care 30 1709-1716
[7]
Adams TD(2013)Exaggerated glucagon-like peptide 1 response is important for improved β-cell function and glucose tolerance after Roux-en-Y gastric bypass in patients with type 2 diabetes Diabetes 62 3044-3052
[8]
Gress RE(2013)Exaggerated release and preserved insulinotropic action of glucagon-like peptide-1 underlie insulin hypersecretion in glucose-tolerant individuals after Roux-en-Y gastric bypass Diabetologia 56 2679-2687
[9]
Smith SC(2005)Physiology and pathophysiology of glucagon-like peptide-1 (GLP-1): the role of GLP-1 in the pathogenesis of diabetes mellitus, obesity, and stress Med Sci Monit 11 RA271-RA278
[10]
Halverson RC(2004)Glucagon-like peptide 1 (GLP-1) and eating Physiol Behav 82 17-19